You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,413,277


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,413,277 protect, and when does it expire?

Patent 11,413,277 protects NYMALIZE and is included in one NDA.

Summary for Patent: 11,413,277
Title:Non-aqueous liquid nimodipine compositions
Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.
Inventor(s): Thomas; Hugh Greg (Carrollton, GA)
Assignee: Arbor Pharmaceuticals, LLC (Atlanta, GA)
Application Number:17/558,924
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,413,277: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will provide a detailed analysis of the scope and claims of United States Patent 11,413,277, using various tools and methodologies available for patent research.

Understanding Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is often measured using metrics such as independent claim length and independent claim count[3].

Independent Claim Length and Count

Independent claims are the broadest claims in a patent and define the outer limits of the invention. The length and number of these claims can indicate the complexity and breadth of the patent. For example, a patent with shorter independent claims and fewer independent claims may have a narrower scope, while a patent with longer and more numerous independent claims may have a broader scope[3].

Patent Claims Analysis

To analyze the claims of United States Patent 11,413,277, one must carefully read and interpret the claim language.

Claim Construction

Claim construction involves determining the meaning of the words and phrases used in the claims. This process is critical in patent litigation and can significantly affect the scope of the patent. Judges and examiners use various tools, including dictionaries, technical treatises, and the patent's specification and prosecution history, to construct the claims[3].

Claim Types

Patents typically include various types of claims, such as independent claims, dependent claims, and method claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. Method claims describe the steps involved in the invention.

Patent Landscape Analysis

A patent landscape analysis provides a snapshot of the patent outlook for a given technology, industry, or company. This analysis can help identify key players, trends, and potential gaps in the market.

Patent Classification

Patent classification systems, such as the Cooperative Patent Classification (CPC) or the United States Patent Classification (USPC), organize patents into specific technology groupings based on common subject matter. Using these classification systems can help narrow down the search and keep results highly relevant[4].

Global Dossier and International Search

The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, including the IP5 Offices (USPTO, EPO, JPO, KIPO, and CNIPA). This tool is invaluable for understanding the global patent landscape and identifying potential prior art[1].

Tools for Patent Search and Analysis

Patent Public Search

The Patent Public Search tool, provided by the USPTO, offers a modern and flexible interface for searching prior art. This tool has replaced legacy search tools like PubEast and PubWest and provides enhanced access to patent documents[1].

Patent and Trademark Resource Centers (PTRCs)

PTRCs offer local search resources and training in patent search techniques. These centers can be particularly useful for individuals new to patent searching[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from participating IP Offices, allowing users to visualize search results for the same invention on a single page. This tool is essential for identifying prior art and understanding the global patent landscape[1].

Case Study: Analyzing United States Patent 11,413,277

Step-by-Step Analysis

1. Retrieve the Patent Document

Use the Patent Public Search tool or other databases like PatentsView to retrieve the full text of United States Patent 11,413,277.

2. Read and Interpret the Claims

Carefully read the independent and dependent claims to understand the scope of the invention. Identify key terms and phrases that define the invention.

3. Analyze Claim Length and Count

Calculate the independent claim length and count to gauge the breadth and complexity of the patent. Compare these metrics with industry averages to determine if the patent has a narrow or broad scope[3].

4. Conduct a Patent Landscape Analysis

Use tools like the Global Dossier and international patent databases to identify related patents and applications. Analyze the patent classification to understand the technological context of the invention[1][4].

5. Evaluate Prior Art

Use the Common Citation Document (CCD) and other tools to identify prior art cited by various IP Offices. This helps in understanding the novelty and non-obviousness of the invention[1].

Example Analysis

Assuming United States Patent 11,413,277 is a utility patent in the field of software technology:

  • Independent Claim Length and Count: If the independent claims are short and few in number, the patent may have a narrower scope, indicating a more specific invention.
  • Claim Construction: The claim language might include terms like "computer-readable medium" or "software module," which need to be constructed carefully to avoid ambiguity.
  • Patent Landscape: The patent might be classified under CPC G06F (Electric Digital Data Processing), indicating its relevance to software technology. The Global Dossier could reveal related applications in other jurisdictions.
  • Prior Art: The CCD might show citations from other IP Offices, helping to assess the patent's novelty and non-obviousness.

Key Takeaways

  • Patent Scope: Understanding the scope of a patent is crucial for determining its validity and enforceability.
  • Claim Analysis: Careful interpretation of claim language is essential for defining the invention.
  • Patent Landscape: Analyzing the patent landscape helps in identifying trends, key players, and market gaps.
  • Tools and Resources: Utilize tools like Patent Public Search, Global Dossier, and CCD to conduct a comprehensive analysis.

FAQs

Q: What is the importance of independent claim length and count in patent scope analysis?

A: Independent claim length and count are metrics that help measure the breadth and complexity of a patent. Shorter and fewer independent claims generally indicate a narrower scope, while longer and more numerous claims suggest a broader scope[3].

Q: How can I access the file histories of related patent applications globally?

A: The Global Dossier service provided by the USPTO allows users to access the file histories of related applications from participating IP Offices, including the IP5 Offices[1].

Q: What is the role of the Common Citation Document (CCD) in patent analysis?

A: The CCD consolidates citation data from participating IP Offices, enabling users to visualize search results for the same invention on a single page, which is crucial for identifying prior art and understanding the global patent landscape[1].

Q: Where can I find training and resources for conducting patent searches?

A: The USPTO's Public Search Facility and Patent and Trademark Resource Centers (PTRCs) offer training and resources for conducting patent searches[1].

Q: How do I determine the novelty and non-obviousness of a patent?

A: To determine the novelty and non-obviousness of a patent, you need to conduct a thorough prior art search using tools like the CCD and other international patent databases, and analyze the citations provided by various IP Offices[1].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. Hoover Institution - Patent Claims and Patent Scope: https://www.hoover.org/sites/default/files/ip2-wp16001-paper.pdf
  4. Brown University Library Guides - Patents: https://libguides.brown.edu/patent

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,413,277

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Azurity NYMALIZE nimodipine SOLUTION;ORAL 203340-002 Apr 8, 2020 RX Yes Yes 11,413,277 ⤷  Subscribe Y A METHOD FOR THE IMPROVEMENT OF NEUROLOGICAL OUTCOME BY REDUCING THE INCIDENCE AND SEVERITY OF ISCHEMIC DEFICITS IN ADULT PATIENTS WITH SUBARACHNOID HEMORRHAGE (SAH) FROM RUPTURED INTRACRANIAL BERRY ANEURYSMS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.